BIOMERICA INC

BMRA is the ticker symbol for BIOMERICA INC, a publicly traded US company.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Key metrics include a return on equity of -39.6%, a debt-to-equity ratio of 0.47.

The company reports trailing twelve-month revenue of $987,000 and net loss of $1.31M.

FINOTAUR aggregates real-time and fundamental data on BMRA to help traders and investors make informed decisions. Track BMRA in your trading journal alongside other positions for a unified view of your portfolio.